REG - Wellington Mngmnt Gp Amgen Inc. - Form 8.3 - Amgen Inc

AmgenAnnouncement

01/12/2022 12:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221201:nRSA2882Ia&default-theme=true

RNS Number : 2882I  Wellington Management Group LLP  01 December 2022

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES

REPRESENTING 1% OR MORE

 1.                                 KEY INFORMATION

 Name of person dealing                                                   Wellington Management Group LLP
 Company dealt in                                                         Amgen Inc.
 Class of relevant security to which the                                  Ordinary Shares (US0311621009)

 dealings being disclosed relate
 Date of dealing                                                          30 November 2022

 2.                                 INTERESTS AND SHORT POSITIONS

 (a)                                Interests and short positions (following dealing) in the class of relevant
                                    security

                                    dealt in

                                                           Long                                         Short
                                                           Number                        (%)            Number          (%)
 (1)         Relevant securities                           55,255 shares                 0.01 %         -8,516 shares   0.00 %
 (2)         Derivatives (other than options):                                                          -1,511 shares   0.00 %
 (3)         Options and agreements to purchase/sell:      1,210 shares                  0.00 %         -1,248 shares   0.00 %
             Total                                         56,465 shares                 0.01 %         -11,275 shares  0.00 %

 (b)                                Interests and short positions in relevant securities of the company, other
                                    than the

                                    class dealt in

 Class of relevant security:                               Long                                         Short
                                                           Number                        (%)            Number          (%)
 (1)         Relevant securities
 (2)         Derivatives (other than options):
 (3)         Options and agreements to purchase/sell:
             Total

 3.               DEALINGS

 (a)              Purchases and sales

 Purchase/sale                                                                                            Number of relevant securities                                                          Price per unit
 Purchase                                                                                                 24 shares                                                                              286.4000 USD

 (b)              Derivatives transactions (other than options transactions)

 Product name                                                                  Nature of transaction                                           Number of relevant securities                               Price per unit

 e.g. CFD

 (c)              Options transactions in respect of existing relevant securities

 (i)              Writing, selling, purchasing or varying

 Product name e.g. call option     Writing, purchasing, selling, varying etc.  Number of securities to which the option relates      Exercise price      Type, e.g. American, European etc.      Expiry date         Option money paid/ received per unit
 Equity Call Option                Sale                                        9,124 shares                                          300.0000USD         American                                16 Dec 22           2.9800 USD
 Equity Call Option                Purchase                                    14 shares                                             295.0000USD         American                                16 Dec 22           2.2200 USD

 (ii)             Exercising

 Product name                                                                  Number of securities                                                                          Exercise price per unit

 e.g. call option

 (d)              Other dealings (including subscribing for new securities)

 Nature of transaction                                                         Details                                                                                       Price per unit (if applicable)

 4.                                 OTHER INFORMATION

 Agreements, arrangements or understandings relating to options or derivatives

 Full details of any agreement, arrangement or understanding between the person
 disclosing and any other person relating to the voting rights of any relevant
 securities under any option referred to on this form or relating to the voting
 rights or future acquisition or disposal of any relevant securities to which
 any derivative referred to on this form is referenced. If none, this should be
 stated.
 None

 Is a Supplemental Form 8 attached?                                    YES

 Date of disclosure                                                    01 December 2022
 Contact name                                                          Shaheen Hussain
 Telephone number                                                      44-20-7126-6099
 If a connected EFM, name of offeree/offeror with which connected
 If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL

ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)

 OPEN POSITIONS

 Product name, e.g. call option  Written or purchased  Number of relevant securities to which option or derivative relates  Exercise price  Type e.g. American, European etc.  Expiry date
 Equity Call Option              Purchased             1,196 shares                                                         300.0000USD     American                           16 Dec 22
 Equity Call Option              Purchased             14 shares                                                            295.0000USD     American                           16 Dec 22
 Equity Put Option               Purchased             1,248 shares                                                         275.0000USD     American                           16 Dec 22
 Equity Swap                     Written               4 shares                                                                                                                15 May 23
 Equity Swap                     Written               5 shares                                                                                                                15 May 23
 Equity Swap                     Written               5 shares                                                                                                                15 May 23
 Equity Swap                     Written               6 shares                                                                                                                15 May 23
 Equity Swap                     Written               6 shares                                                                                                                15 May 23
 Equity Swap                     Written               6 shares                                                                                                                15 May 23
 Equity Swap                     Written               6 shares                                                                                                                15 May 23
 Equity Swap                     Written               6 shares                                                                                                                15 May 23
 Equity Swap                     Written               7 shares                                                                                                                15 May 23
 Equity Swap                     Written               7 shares                                                                                                                15 May 23
 Equity Swap                     Written               14 shares                                                                                                               15 May 23
 Equity Swap                     Written               16 shares                                                                                                               15 May 23
 Equity Swap                     Written               18 shares                                                                                                               22 May 23
 Equity Swap                     Written               21 shares                                                                                                               15 May 23
 Equity Swap                     Written               21 shares                                                                                                               22 May 23
 Equity Swap                     Written               38 shares                                                                                                               15 May 23
 Equity Swap                     Written               307 shares                                                                                                              15 May 23
 Equity Swap                     Written               1,018 shares                                                                                                            15 May 23

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ISETBBTTMTMMBFT